Derek C. Radisky
Nature Reviews. Cancer · 2001–2005
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 15 researchers here, as inferred from the citation graph.
Who trusts Derek C. Radisky overall
- Pengfei Lu
- A. Orimo
- T. Yuan
- Kenneth M. Yamada
- Peter Friedl
- R. Weinberg
- Mina J. Bissell
- M. Taddei
- M. Egeblad
- K. Polyak
Papers from Derek C. Radisky's perspective
Ordered by how strongly the researchers Derek C. Radisky trusts endorse each paper. Same corpus, a different order for every researcher.
- Development of matrix metalloproteinase inhibitors in cancer therapy. (Journal of the National Cancer Institute)
- Anoikis mechanisms. (Current Opinion in Cell Biology)
- beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. (Cancer Cell)
- Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. (New England Journal of Medicine)
- Matrix metalloproteinases: effectors of development and normal physiology. (Genes & Development)
- Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis (Journal of Cell Biology)
- Role of BAX in the apoptotic response to anticancer agents. (Science)
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
- If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. (Drug resistance updates)
- DNA and its associated processes as targets for cancer therapy (Nature Reviews. Cancer)
Their papers
- Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability (2005) — 1,325 citations
- The organizing principle: microenvironmental influences in the normal and malignant breast. (2002) — 615 citations
- Putting tumours in context (2001) — 2,104 citations